Tirzepatide is a synthetic peptide belonging to the dual incretin receptor agonist class. It is characterised by activity at both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors.

LIFE supplies Tirzepatide 10 mg as a high-purity, lyophilised peptide for laboratory and analytical research. Each batch is accompanied by a Certificate of Analysis (COA), with additional independent laboratory verification available for selected batches.

Product characteristics

Specification	Details
Product	Tirzepatide (LY3298176)
Quantity	10 mg per vial
Form	Lyophilised powder
Purity	≥99% (HPLC)
Molecular weight	4813.45 g/mol
Molecular formula	C₂₂₅H₃₄₈N₄₈O₆₈
Research category	Dual GIP/GLP-1 receptor agonist
Storage	Refrigerated at 2–8°C
Intended application	Laboratory and analytical research

Quality control

LIFE Tirzepatide 10 mg is supplied with batch-specific analytical documentation. The current batch has undergone additional independent verification by Janoshik Analytical.

Test information	Result
Batch	TR10-260423
Internal HPLC purity	99.13%
Independent HPLC purity	99.62%
Independent laboratory	Janoshik Analytical

View Independent Laboratory Report

View Certificate of Analysis

Further information

For a comparison of related compounds and their receptor profiles, see our Retatrutide vs Tirzepatide research comparison.

For general laboratory preparation and handling, consult our Peptide Reconstitution Guide.

Disclaimer
This product is sold for research purposes only. It is not intended to diagnose, treat, cure, or prevent any disease. Buyer assumes full responsibility for proper handling and use.

Agonista GIP/GLP-1

Tirzepatide 10 mg